CVRF
  • Login
  • Register
  • CVRF's Meetings
    TCTAP AP VALVES & SH COMPLEX PCI

SummitMD SummitMD

  • Home
  • News
    • SummitMD News
    • Conference News
      • TCTAP
      • AP VALVES & SH
      • COMPLEX PCI
      • ACT PROGRAM
  • Videos
    • TCTAP
    • AP VALVES & SH
    • COMPLEX PCI
    • ACT PROGRAM
  • Slides
    • Coronary
    • Endovascular
    • Structural Heart Disease
    • Valve
    • Imaging & Physiology
    • Pharmacology
  • Book
  • Conferences
    • TCTAP
    • AP VALVES & STRUCTURAL HEART
    • COMPLEX PCI
  • About CVRF
    • Mission
    • Board Members
    • R&D Divisions
      • Clinical Research Coordinating Center
      • Translational Research Center
      • Research Activity
      • Paper Publication
    • Education
      • ACT Program
      • Website

Slides TCTAP

  • Home
  • Slides
No Title Presenter Date
6890 HALT-Pathologic Underpinnings Aloke V. Finn May. 08. 23
6889 Should Jardiance be Used as 1st Essential Medication for Heart Failure, Regardless of LVEF? Kyung Hoon Cho Apr. 20. 23
6888 Jardiance, The First Successful Result for Heart Failure with Preserved Ejection Fraction Wonjae Lee Apr. 20. 23
6887 My First Impression on using Sentinel Device during TAVI Si-Hyuck Kang Apr. 20. 23
6886 Why Should We Consider ACURATE neo2 ? - Based on Clinical Evidence Jeehoon Kang Apr. 20. 23
6885 Introduction to a New TAVI Valve - ACURATE neo2 Cheol Woong Yu Apr. 20. 23
6884 FFR Pullback Quantification to Guide Intervention: The Ongoing PPG Global Registry Nils Johnson Apr. 20. 23
6883 CT Guided PCI: A Novel Approach for Imaging Guided Interventions Carlos Collet Apr. 20. 23
6882 Precision Approaches for Acute Coronary Syndrome Based on OCT-determined Pathogenesis Yoshiyasu Minami Apr. 20. 23
6881 Role of Angio-based FFR for the Planning of PCI Hitoshi Matsuo Apr. 20. 23
1 2 3 4 5 6 7 8 9 10 ¢º
Conference Slides
  • TCTAP
  • AP VALVES & SH
  • COMPLEX PCI
Category

Coronary

  • Left Main
  • Bifurcation
  • CTO
  • Long Lesion
  • Ostial
  • In-stent Restenosis
  • Others

Endovascular

  • Carotid
  • Peripheral Disease
    • SFA
    • BTK
    • Iliac
    • Poplitial
    • Subclavian
  • Abdominal Aorta
  • Renal
  • Others

Structural Heart Disease

  • Congenital Heart Disease
  • HOCM
  • Others

Valve

  • TAVR
  • Others

Imaging & Physiology

  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others

Pharmacology

  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others

CVRF
CardioVascular Research Foundation
Àç´Ü¹ýÀÎ ½ÉÀåÇ÷°ü¿¬±¸Àç´Ü
2F Asan Institute for Education & Research
88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul 05505, Korea
´ëÇ¥ÀÚ: ¹Ú½ÂÁ¤ | ÀüÈ­¹øÈ£: 02-3010-4720
»ç¾÷ÀÚµî·Ï¹øÈ£: 215-82-06387

Privacy Policy

The Latest News
  • Extended BEST trial offers insight into murky dispute over optimal long-term revasc strategy in MVCAD
    23-01-06
  • TAVI noninferior to surgery for elderly, severe AS patients at moderate operative risk: UK TAVI
    22-10-14
  • [DOWNLOAD FREE EBOOK] Technical Forum A to Z: Complex Coronary Intervention - 3rd Edition
    22-10-7
Porto Website Template

Copyright 2002. All Rights Reserved.